A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19
NCT ID: NCT05042232
Last Updated: 2022-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
239 participants
OBSERVATIONAL
2021-04-19
2022-06-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mind Body Intervention for Long COVID-19
NCT06045338
Self-Management Interventions for Long COVID-19
NCT05268523
Long COVID-19 Intervention Using Digital Health & Technology
NCT05616806
Chronic-disease Self-management Program in Patients Living With Long-COVID in Puerto Rico
NCT06208696
Lift Mobile Mindfulness for COVID-19 Distress Symptoms
NCT04581200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SARS-CoV-2 Positive
Participants who have tested positive for SARS-CoV-2, both with and without symptoms
SARS-CoV-2 Negative
Participants who have tested negative for SARS-CoV-2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals with a valid diagnostic COVID-19 test result
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Everly Health
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy Bauer, PhD
Role: PRINCIPAL_INVESTIGATOR
Everly Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Everlywell, Inc
Austin, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EW-US-4010-0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.